6-tert-butyl-1-cyclohexylindazole;5-tert-butyl-1-methylbenzimidazole;5-tert-butyl-4-methyl-1,4-benzoxazin-3-one;5-tert-butyl-4-methyl-2,3-dihydro-1,4-benzoxazine;8-tert-butyl-2-methylidene-1H-quinoxaline;4-tert-butyl-1-methylindazole;6-tert-butyl-1-(1-methylpiperidin-4-yl)indazole;1-tert-butylnaphthalene;4-tert-butyloxane;8-tert-butyl-2-piperidin-1-ylquinoline;5-tert-butylquinoxaline;5-tert-butyl-1,2,3,4-tetrahydroquinoline

C163H224N18O4 — CID 157390973

IUPAC6-tert-butyl-1-cyclohexylindazole;5-tert-butyl-1-methylbenzimidazole;5-tert-butyl-4-methyl-1,4-benzoxazin-3-one;5-tert-butyl-4-methyl-2,3-dihydro-1,4-benzoxazine;8-tert-butyl-2-methylidene-1H-quinoxaline;4-tert-butyl-1-methylindazole;6-tert-butyl-1-(1-methylpiperidin-4-yl)indazole;1-tert-butylnaphthalene;4-tert-butyloxane;8-tert-butyl-2-piperidin-1-ylquinoline;5-tert-butylquinoxaline;5-tert-butyl-1,2,3,4-tetrahydroquinoline
SMILESC=C1C=Nc2cccc(C(C)(C)C)c2N1.CC(C)(C)C1CCOCC1.CC(C)(C)c1ccc2cnn(C3CCCCC3)c2c1.CC(C)(C)c1cccc2c1CCCN2.CC(C)(C)c1cccc2ccc(N3CCCCC3)nc12.CC(C)(C)c1cccc2ccccc12.CC(C)(C)c1cccc2nccnc12.CN1C(=O)COc2cccc(C(C)(C)C)c21.CN1CCC(n2ncc3ccc(C(C)(C)C)cc32)CC1.CN1CCOc2cccc(C(C)(C)C)c21.Cn1cnc2cc(C(C)(C)C)ccc21.Cn1ncc2c(C(C)(C)C)cccc21
InChIInChI=1S/C18H24N2.C17H25N3.C17H24N2.C14H16.C13H16N2.C13H17NO2.C13H19NO.C13H19N.2C12H16N2.C12H14N2.C9H18O/c1-18(2,3)15-9-7-8-14-10-11-16(19-17(14)15)20-12-5-4-6-13-20;1-17(2,3)14-6-5-13-12-18-20(16(13)11-14)15-7-9-19(4)10-8-15;1-17(2,3)14-10-9-13-12-18-19(16(13)11-14)15-7-5-4-6-8-15;1-14(2,3)13-10-6-8-11-7-4-5-9-12(11)13;1-9-8-14-11-7-5-6-10(12(11)15-9)13(2,3)4;1-13(2,3)9-6-5-7-10-12(9)14(4)11(15)8-16-10;1-13(2,3)10-6-5-7-11-12(10)14(4)8-9-15-11;1-13(2,3)11-7-4-8-12-10(11)6-5-9-14-12;1-12(2,3)9-5-6-11-10(7-9)13-8-14(11)4;1-12(2,3)10-6-5-7-11-9(10)8-13-14(11)4;1-12(2,3)9-5-4-6-10-11(9)14-8-7-13-10;1-9(2,3)8-4-6-10-7-5-8/h7-11H,4-6,12-13H2,1-3H3;5-6,11-12,15H,7-10H2,1-4H3;9-12,15H,4-8H2,1-3H3;4-10H,1-3H3;5-8,15H,1H2,2-4H3;5-7H,8H2,1-4H3;5-7H,8-9H2,1-4H3;4,7-8,14H,5-6,9H2,1-3H3;2*5-8H,1-4H3;4-8H,1-3H3;8H,4-7H2,1-3H3
InChIKeyBLZQHVCSTRDUAQ-UHFFFAOYSA-N
MW2499.71 g/mol
LogP40.35
Rot. Bonds3

About 6-tert-butyl-1-cyclohexylindazole;5-tert-butyl-1-methylbenzimidazole;5-tert-butyl-4-methyl-1,4-benzoxazin-3-one;5-tert-butyl-4-methyl-2,3-dihydro-1,4-benzoxazine;8-tert-butyl-2-methylidene-1H-quinoxaline;4-tert-butyl-1-methylindazole;6-tert-butyl-1-(1-methylpiperidin-4-yl)indazole;1-tert-butylnaphthalene;4-tert-butyloxane;8-tert-butyl-2-piperidin-1-ylquinoline;5-tert-butylquinoxaline;5-tert-butyl-1,2,3,4-tetrahydroquinoline

6-tert-butyl-1-cyclohexylindazole;5-tert-butyl-1-methylbenzimidazole;5-tert-butyl-4-methyl-1,4-benzoxazin-3-one;5-tert-butyl-4-methyl-2,3-dihydro-1,4-benzoxazine;8-tert-butyl-2-methylidene-1H-quinoxaline;4-tert-butyl-1-methylindazole;6-tert-butyl-1-(1-methylpiperidin-4-yl)indazole;1-tert-butylnaphthalene;4-tert-butyloxane;8-tert-butyl-2-piperidin-1-ylquinoline;5-tert-butylquinoxaline;5-tert-butyl-1,2,3,4-tetrahydroquinoline (PubChem CID 157390973) has the molecular formula C163H224N18O4 and a molecular weight of 2499.71 g/mol. Its IUPAC name is 6-tert-butyl-1-cyclohexylindazole;5-tert-butyl-1-methylbenzimidazole;5-tert-butyl-4-methyl-1,4-benzoxazin-3-one;5-tert-butyl-4-methyl-2,3-dihydro-1,4-benzoxazine;8-tert-butyl-2-methylidene-1H-quinoxaline;4-tert-butyl-1-methylindazole;6-tert-butyl-1-(1-methylpiperidin-4-yl)indazole;1-tert-butylnaphthalene;4-tert-butyloxane;8-tert-butyl-2-piperidin-1-ylquinoline;5-tert-butylquinoxaline;5-tert-butyl-1,2,3,4-tetrahydroquinoline.

Molecular Properties

Compound Name6-tert-butyl-1-cyclohexylindazole;5-tert-butyl-1-methylbenzimidazole;5-tert-butyl-4-methyl-1,4-benzoxazin-3-one;5-tert-butyl-4-methyl-2,3-dihydro-1,4-benzoxazine;8-tert-butyl-2-methylidene-1H-quinoxaline;4-tert-butyl-1-methylindazole;6-tert-butyl-1-(1-methylpiperidin-4-yl)indazole;1-tert-butylnaphthalene;4-tert-butyloxane;8-tert-butyl-2-piperidin-1-ylquinoline;5-tert-butylquinoxaline;5-tert-butyl-1,2,3,4-tetrahydroquinoline
PubChem CID157390973
Molecular FormulaC163H224N18O4
Molecular Weight2499.71 g/mol
Exact Mass2497.79
IUPAC Name6-tert-butyl-1-cyclohexylindazole;5-tert-butyl-1-methylbenzimidazole;5-tert-butyl-4-methyl-1,4-benzoxazin-3-one;5-tert-butyl-4-methyl-2,3-dihydro-1,4-benzoxazine;8-tert-butyl-2-methylidene-1H-quinoxaline;4-tert-butyl-1-methylindazole;6-tert-butyl-1-(1-methylpiperidin-4-yl)indazole;1-tert-butylnaphthalene;4-tert-butyloxane;8-tert-butyl-2-piperidin-1-ylquinoline;5-tert-butylquinoxaline;5-tert-butyl-1,2,3,4-tetrahydroquinoline
SMILESC=C1C=Nc2cccc(C(C)(C)C)c2N1.CC(C)(C)C1CCOCC1.CC(C)(C)c1ccc2cnn(C3CCCCC3)c2c1.CC(C)(C)c1cccc2c1CCCN2.CC(C)(C)c1cccc2ccc(N3CCCCC3)nc12.CC(C)(C)c1cccc2ccccc12.CC(C)(C)c1cccc2nccnc12.CN1C(=O)COc2cccc(C(C)(C)C)c21.CN1CCC(n2ncc3ccc(C(C)(C)C)cc32)CC1.CN1CCOc2cccc(C(C)(C)C)c21.Cn1cnc2cc(C(C)(C)C)ccc21.Cn1ncc2c(C(C)(C)C)cccc21
InChIInChI=1S/C18H24N2.C17H25N3.C17H24N2.C14H16.C13H16N2.C13H17NO2.C13H19NO.C13H19N.2C12H16N2.C12H14N2.C9H18O/c1-18(2,3)15-9-7-8-14-10-11-16(19-17(14)15)20-12-5-4-6-13-20;1-17(2,3)14-6-5-13-12-18-20(16(13)11-14)15-7-9-19(4)10-8-15;1-17(2,3)14-10-9-13-12-18-19(16(13)11-14)15-7-5-4-6-8-15;1-14(2,3)13-10-6-8-11-7-4-5-9-12(11)13;1-9-8-14-11-7-5-6-10(12(11)15-9)13(2,3)4;1-13(2,3)9-6-5-7-10-12(9)14(4)11(15)8-16-10;1-13(2,3)10-6-5-7-11-12(10)14(4)8-9-15-11;1-13(2,3)11-7-4-8-12-10(11)6-5-9-14-12;1-12(2,3)9-5-6-11-10(7-9)13-8-14(11)4;1-12(2,3)10-6-5-7-11-9(10)8-13-14(11)4;1-12(2,3)9-5-4-6-10-11(9)14-8-7-13-10;1-9(2,3)8-4-6-10-7-5-8/h7-11H,4-6,12-13H2,1-3H3;5-6,11-12,15H,7-10H2,1-4H3;9-12,15H,4-8H2,1-3H3;4-10H,1-3H3;5-8,15H,1H2,2-4H3;5-7H,8H2,1-4H3;5-7H,8-9H2,1-4H3;4,7-8,14H,5-6,9H2,1-3H3;2*5-8H,1-4H3;4-8H,1-3H3;8H,4-7H2,1-3H3
InChIKeyBLZQHVCSTRDUAQ-UHFFFAOYSA-N
XLogP40.35
TPSA204.09 Ų
H-Bond Donors2
H-Bond Acceptors21
Rotatable Bonds3
Heavy Atoms185
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002499.71
LogP ≤ 540.35
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1021

Analyze 6-tert-butyl-1-cyclohexylindazole;5-tert-butyl-1-methylbenzimidazole;5-tert-butyl-4-methyl-1,4-benzoxazin-3-one;5-tert-butyl-4-methyl-2,3-dihydro-1,4-benzoxazine;8-tert-butyl-2-methylidene-1H-quinoxaline;4-tert-butyl-1-methylindazole;6-tert-butyl-1-(1-methylpiperidin-4-yl)indazole;1-tert-butylnaphthalene;4-tert-butyloxane;8-tert-butyl-2-piperidin-1-ylquinoline;5-tert-butylquinoxaline;5-tert-butyl-1,2,3,4-tetrahydroquinoline with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

US20240150366, Example 9
CID 164875490
US20240150366, Example 1
CID 171918775
US20240150366, Example 8
CID 171918776
US20240150366, Example 10
CID 171918777
US20240150366, Example 23
CID 171918781
1-[4-[7-[4-[(5S)-5-[[7-(5-methoxy-1H-indazol-4-yl)-4-(4-prop-2-enoylpiperazin-1-yl)-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-2-yl]oxymethyl]-1-methylpyrrolidin-3-yl]-2-propan-2-ylphenyl]-2-[[(2S)-1-methyl-4-[3-[2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-4-(4-prop-2-enoylpiperazin-1-yl)-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-7-yl]-4-(trifluoromethyl)phenyl]pyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-4-yl]piperazin-1-yl]prop-2-en-1-one
CID 132163250
2-[(2S)-4-[2-[[(2S)-4-[7-[4-[(3S)-3-(cyanomethyl)-4-prop-2-enoylpiperazin-1-yl]-2-[[(2S)-4-[3-[4-[(3S)-3-(cyanomethyl)-4-prop-2-enoylpiperazin-1-yl]-2-[[(2S,4R)-4-fluoro-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-7-yl]-4,5-dimethylphenyl]-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-7-yl]-1-methylindol-5-yl]-1-methylpyrrolidin-2-yl]methoxy]-7-(2,3-dihydro-1-benzofuran-7-yl)-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-4-yl]-1-prop-2-enoylpiperazin-2-yl]acetonitrile
CID 146478400
2-[3-[6-[4-[2-[3-[6-[2-[[2-[3-[5-fluoro-4-(1H-indazol-5-ylamino)pyrrolo[2,1-f][1,2,4]triazin-2-yl]phenoxy]acetyl]amino]propyl]-4-(1H-indazol-5-ylamino)pyrrolo[2,1-f][1,2,4]triazin-2-yl]phenoxy]acetyl]morpholin-2-yl]-4-[4-(1H-pyrazol-4-yl)anilino]pyrrolo[2,1-f][1,2,4]triazin-2-yl]phenoxy]-N-propan-2-ylacetamide
CID 155227879
1-Tert-butyl-9-(1-tert-butylpyridin-1-ium-2-yl)carbazole;1-tert-butyl-2-(1-propan-2-ylimidazol-2-yl)pyridin-1-ium;ethane;2-(1,1,1,3,3,3-hexafluoro-2-propan-2-yloxypropan-2-yl)-1-propan-2-ylpyridin-1-ium;1-propan-2-yl-8-propan-2-yloxy-1,5-naphthyridin-1-ium;1-propan-2-yl-8-propan-2-yloxyquinolin-1-ium;1-propan-2-yl-2-(2-propan-2-ylpyrazol-3-yl)pyridin-1-ium;1-propan-2-yl-2-(1-propan-2-ylpyridin-1-ium-2-yl)benzimidazole
CID 157198497
3-cyclopropyl-1-[7-(difluoromethyl)-6-(1-methylpyrrol-3-yl)-3,4-dihydro-2H-quinolin-1-yl]-N-methyl-6,8-dihydro-5H-imidazo[1,5-a]pyrazine-7-carboxamide;1-[3-cyclopropyl-1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]ethanone;1-[3-cyclopropyl-1-[7-(1-methylpyrrol-3-yl)-6-(trifluoromethoxy)quinolin-4-yl]-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]propan-1-one;2-fluoro-1-[1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(oxolan-3-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]ethanone;methyl 1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(oxolan-3-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazine-7-carboxylate
CID 158056799
tert-butyl 5-(4-tert-butylphenoxy)pentanoate;6-tert-butyl-3,4-dihydro-2H-1,4-benzoxazine;5-tert-butyl-1H-isoindole;5-tert-butyl-1-methylindazole;1-[3-(3-tert-butylphenoxy)propyl]imidazole;4-[3-(3-tert-butylphenoxy)propyl]morpholine;4-(4-tert-butylphenyl)morpholine;1-tert-butyl-3-(trifluoromethoxy)benzene
CID 158986076
N-(3-cyclohexyl-1-propan-2-ylpyrazol-5-yl)-8-(4-fluoro-2-methoxyphenyl)quinazolin-2-amine;8-(4-fluoro-2-methoxyphenyl)-N-(4-piperidin-4-yl-2,3-dihydro-1-benzofuran-7-yl)quinazolin-2-amine;8-(5-fluoro-2-methoxyphenyl)-N-(4-piperidin-4-yl-2,3-dihydro-1-benzofuran-7-yl)quinazolin-2-amine;8-[2-methoxy-4-(trifluoromethyl)phenyl]-N-(4-piperidin-4-yl-2,3-dihydro-1-benzofuran-7-yl)quinazolin-2-amine
CID 159319998

Frequently Asked Questions

What is the IUPAC name of 6-tert-butyl-1-cyclohexylindazole;5-tert-butyl-1-methylbenzimidazole;5-tert-butyl-4-methyl-1,4-benzoxazin-3-one;5-tert-butyl-4-methyl-2,3-dihydro-1,4-benzoxazine;8-tert-butyl-2-methylidene-1H-quinoxaline;4-tert-butyl-1-methylindazole;6-tert-butyl-1-(1-methylpiperidin-4-yl)indazole;1-tert-butylnaphthalene;4-tert-butyloxane;8-tert-butyl-2-piperidin-1-ylquinoline;5-tert-butylquinoxaline;5-tert-butyl-1,2,3,4-tetrahydroquinoline?
The IUPAC name of 6-tert-butyl-1-cyclohexylindazole;5-tert-butyl-1-methylbenzimidazole;5-tert-butyl-4-methyl-1,4-benzoxazin-3-one;5-tert-butyl-4-methyl-2,3-dihydro-1,4-benzoxazine;8-tert-butyl-2-methylidene-1H-quinoxaline;4-tert-butyl-1-methylindazole;6-tert-butyl-1-(1-methylpiperidin-4-yl)indazole;1-tert-butylnaphthalene;4-tert-butyloxane;8-tert-butyl-2-piperidin-1-ylquinoline;5-tert-butylquinoxaline;5-tert-butyl-1,2,3,4-tetrahydroquinoline (CID 157390973) is 6-tert-butyl-1-cyclohexylindazole;5-tert-butyl-1-methylbenzimidazole;5-tert-butyl-4-methyl-1,4-benzoxazin-3-one;5-tert-butyl-4-methyl-2,3-dihydro-1,4-benzoxazine;8-tert-butyl-2-methylidene-1H-quinoxaline;4-tert-butyl-1-methylindazole;6-tert-butyl-1-(1-methylpiperidin-4-yl)indazole;1-tert-butylnaphthalene;4-tert-butyloxane;8-tert-butyl-2-piperidin-1-ylquinoline;5-tert-butylquinoxaline;5-tert-butyl-1,2,3,4-tetrahydroquinoline.
What is the SMILES notation for 6-tert-butyl-1-cyclohexylindazole;5-tert-butyl-1-methylbenzimidazole;5-tert-butyl-4-methyl-1,4-benzoxazin-3-one;5-tert-butyl-4-methyl-2,3-dihydro-1,4-benzoxazine;8-tert-butyl-2-methylidene-1H-quinoxaline;4-tert-butyl-1-methylindazole;6-tert-butyl-1-(1-methylpiperidin-4-yl)indazole;1-tert-butylnaphthalene;4-tert-butyloxane;8-tert-butyl-2-piperidin-1-ylquinoline;5-tert-butylquinoxaline;5-tert-butyl-1,2,3,4-tetrahydroquinoline?
The canonical SMILES for 6-tert-butyl-1-cyclohexylindazole;5-tert-butyl-1-methylbenzimidazole;5-tert-butyl-4-methyl-1,4-benzoxazin-3-one;5-tert-butyl-4-methyl-2,3-dihydro-1,4-benzoxazine;8-tert-butyl-2-methylidene-1H-quinoxaline;4-tert-butyl-1-methylindazole;6-tert-butyl-1-(1-methylpiperidin-4-yl)indazole;1-tert-butylnaphthalene;4-tert-butyloxane;8-tert-butyl-2-piperidin-1-ylquinoline;5-tert-butylquinoxaline;5-tert-butyl-1,2,3,4-tetrahydroquinoline is C=C1C=Nc2cccc(C(C)(C)C)c2N1.CC(C)(C)C1CCOCC1.CC(C)(C)c1ccc2cnn(C3CCCCC3)c2c1.CC(C)(C)c1cccc2c1CCCN2.CC(C)(C)c1cccc2ccc(N3CCCCC3)nc12.CC(C)(C)c1cccc2ccccc12.CC(C)(C)c1cccc2nccnc12.CN1C(=O)COc2cccc(C(C)(C)C)c21.CN1CCC(n2ncc3ccc(C(C)(C)C)cc32)CC1.CN1CCOc2cccc(C(C)(C)C)c21.Cn1cnc2cc(C(C)(C)C)ccc21.Cn1ncc2c(C(C)(C)C)cccc21.
What is the InChIKey of 6-tert-butyl-1-cyclohexylindazole;5-tert-butyl-1-methylbenzimidazole;5-tert-butyl-4-methyl-1,4-benzoxazin-3-one;5-tert-butyl-4-methyl-2,3-dihydro-1,4-benzoxazine;8-tert-butyl-2-methylidene-1H-quinoxaline;4-tert-butyl-1-methylindazole;6-tert-butyl-1-(1-methylpiperidin-4-yl)indazole;1-tert-butylnaphthalene;4-tert-butyloxane;8-tert-butyl-2-piperidin-1-ylquinoline;5-tert-butylquinoxaline;5-tert-butyl-1,2,3,4-tetrahydroquinoline?
The InChIKey is BLZQHVCSTRDUAQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H24N2.C17H25N3.C17H24N2.C14H16.C13H16N2.C13H17NO2.C13H19NO.C13H19N.2C12H16N2.C12H14N2.C9H18O/c1-18(2,3)15-9-7-8-14-10-11-16(19-17(14)15)20-12-5-4-6-13-20;1-17(2,3)14-6-5-13-12-18-20(16(13)11-14)15-7-9-19(4)10-8-15;1-17(2,3)14-10-9-13-12-18-19(16(13)11-14)15-7-5-4-6-8-15;1-14(2,3)13-10-6-8-11-7-4-5-9-12(11)13;1-9-8-14-11-7-5-6-10(12(11)15-9)13(2,3)4;1-13(2,3)9-6-5-7-10-12(9)14(4)11(15)8-16-10;1-13(2,3)10-6-5-7-11-12(10)14(4)8-9-15-11;1-13(2,3)11-7-4-8-12-10(11)6-5-9-14-12;1-12(2,3)9-5-6-11-10(7-9)13-8-14(11)4;1-12(2,3)10-6-5-7-11-9(10)8-13-14(11)4;1-12(2,3)9-5-4-6-10-11(9)14-8-7-13-10;1-9(2,3)8-4-6-10-7-5-8/h7-11H,4-6,12-13H2,1-3H3;5-6,11-12,15H,7-10H2,1-4H3;9-12,15H,4-8H2,1-3H3;4-10H,1-3H3;5-8,15H,1H2,2-4H3;5-7H,8H2,1-4H3;5-7H,8-9H2,1-4H3;4,7-8,14H,5-6,9H2,1-3H3;2*5-8H,1-4H3;4-8H,1-3H3;8H,4-7H2,1-3H3.
What are the key properties of 6-tert-butyl-1-cyclohexylindazole;5-tert-butyl-1-methylbenzimidazole;5-tert-butyl-4-methyl-1,4-benzoxazin-3-one;5-tert-butyl-4-methyl-2,3-dihydro-1,4-benzoxazine;8-tert-butyl-2-methylidene-1H-quinoxaline;4-tert-butyl-1-methylindazole;6-tert-butyl-1-(1-methylpiperidin-4-yl)indazole;1-tert-butylnaphthalene;4-tert-butyloxane;8-tert-butyl-2-piperidin-1-ylquinoline;5-tert-butylquinoxaline;5-tert-butyl-1,2,3,4-tetrahydroquinoline?
6-tert-butyl-1-cyclohexylindazole;5-tert-butyl-1-methylbenzimidazole;5-tert-butyl-4-methyl-1,4-benzoxazin-3-one;5-tert-butyl-4-methyl-2,3-dihydro-1,4-benzoxazine;8-tert-butyl-2-methylidene-1H-quinoxaline;4-tert-butyl-1-methylindazole;6-tert-butyl-1-(1-methylpiperidin-4-yl)indazole;1-tert-butylnaphthalene;4-tert-butyloxane;8-tert-butyl-2-piperidin-1-ylquinoline;5-tert-butylquinoxaline;5-tert-butyl-1,2,3,4-tetrahydroquinoline has a molecular weight of 2499.71 g/mol, XLogP of 40.35, 3 rotatable bonds, 2 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for 6-tert-butyl-1-cyclohexylindazole;5-tert-butyl-1-methylbenzimidazole;5-tert-butyl-4-methyl-1,4-benzoxazin-3-one;5-tert-butyl-4-methyl-2,3-dihydro-1,4-benzoxazine;8-tert-butyl-2-methylidene-1H-quinoxaline;4-tert-butyl-1-methylindazole;6-tert-butyl-1-(1-methylpiperidin-4-yl)indazole;1-tert-butylnaphthalene;4-tert-butyloxane;8-tert-butyl-2-piperidin-1-ylquinoline;5-tert-butylquinoxaline;5-tert-butyl-1,2,3,4-tetrahydroquinoline is sourced from PubChem (CID 157390973), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).